Tissue Bank Challenges Repository and Pathologist View Elizabeth H. Hammond M.D.

Slides:



Advertisements
Similar presentations
The Role of the IRB An Institutional Review Board (IRB) is a review committee established to help protect the rights and welfare of human research subjects.
Advertisements

Tips to a Successful Monitoring Visit
Ann Johnson IRB Administrator, IRB Member. Objectives 1. Identify the components necessary for management and oversight of tissue repositories used for.
TISSUE BANKING Challenging to Say the Least
Documentation and Maintenance of Records What You Should Know and Why Program Training For Medicaid Providers of Home and Community Care Services Home.
Introduction to Records Management Policy
QI project or research? Thomas F. Byrd M.D. HRRC Chair Subcommitees 2 and 4 December 3, 2013.
ISO in Histopathology Louise O’Callaghan MSc FAMLS
Presented by Elena Chan, UCSF Pharm.D. Candidate Tiffany Jew, USC Pharm.D. Candidate March 14, 2007 P HARMACEUTICAL C ONSULTANTS, I NC. P RO P HARMA HIPAA.
1 The HIPAA Privacy Rule and Research This presentation will probably involve audience discussion, which will create action items. Use PowerPoint to keep.
HIPAA – Privacy Rule and Research USCRF Research Educational Series March 19, 2003.
National Cancer Institute Cancer Therapy Evaluation Program (CTEP) presents: How to Obtain Protected Health Information (PHI) from an Outside Healthcare.
NCVHS: Privacy and Confidentiality Leslie P. Francis, Ph.D., J.D. Distinguished Professor of Law and Philosophy Alfred C. Emery Professor of Law University.
UTHSC IRB Donna Hollaway, RN, CCRC 11/30/2011 Authority to Audit 45 CFR (e) An IRB shall conduct continuing review of research covered by this.
Health Insurance Portability Accountability Act of 1996 HIPAA for Researchers: IRB Related Issues HSC USC IRB.
1 1 Chapter 1 Specimen Management Professor A. S. Alhomida Disclaimer The texts, tables and images contained in this course presentation (BCH 376) are.
Methods repositories use to protect subjects Roger Aamodt, Ph.D. Resources Development Branch, National Cancer Institute.
Recently Issued OHRP Documents: Guidance on Subject Withdrawal and Draft Revised FWA Secretary’s Advisory Committee on Human Research Protections October.
Developing a Records & Information Retention & Disposition Program:
Chapter 5: The Behavior Analyst’s Responsibility to Clients Guideline 2 Leigh O’Brien Caldwell College.
CUMC IRB Investigator Meeting IRB Frequently Asked Questions October 11, 2005.
HIPAA COMPLIANCE IN YOUR PRACTICE MARIBEL VALENTIN, ESQUIRE.
Human Research Protection Programs 1a: How to Navigate Human Subject Protection Regulations Sponsored by the American Society for Investigative Pathology.
Treuman Katz Center for Pediatric Bioethics Conference Banking Biological Samples for Pediatric Research Jeffrey R. Botkin, M.D., M.P.H. Professor.
International Research & Research Involving Children K. Lynn Cates, MD Assistant Chief Research & Development Officer Office of Research & Development.
Electronic Records Management: What Management Needs to Know May 2009.
Role of the Oncology Research Team Carmen B. Jacobs, RN, OCN, CCRP.
Pre-Award Issues Related to Human Research and Animal Use March 15, 2013.
Computerized Networking of HIV Providers Workshop Data Security, Privacy and HIPAA: Focus on Privacy Joy L. Pritts, J.D. Assistant Research Professor Health.
Implications for the Use of Tissue in Research P. Pearl O’Rourke, MD Partners HealthCare Boston, MA.
CLINICAL RESEARCH STUDIES Janette Hannam, MS, CTRA Asst. Director for Research, OSP.
HIPAA and Research Basics for IRB Tim Atkinson Director, Research and Sponsored Programs Director, Institutional Review Board Research Privacy Officer.
HIPAA – How Will the Regulations Impact Research?.
RISK MANAGEMENT IN THE TREATMENT OF OPIOID DEPENDENCE Presented by: Barbara A. M. Maloney, Esq.
Ethical and Regulatory Considerations in Research using Residual Specimens Jeffrey R. Botkin, M.D., M.P.H. Professor of Pediatrics and Medical Ethics Associate.
Joyce Mull, MPM Director, Regulatory Affairs National Surgical Adjuvant Breast and Bowel Project Consent Form and IRB Challenges that Arise with Specimen.
H I P A A T R A I N I N G Self Directed Module 7 Research Disclosures For Data Custodians START Click to begin…
Medical Law and Ethics, Third Edition Bonnie F. Fremgen Copyright ©2009 by Pearson Education, Inc. Upper Saddle River, New Jersey All rights reserved.
Consent for Research Study A study for patients diagnosed with locally advanced breast cancer Learning if the imaging agent, [ 18 F] fluorothymidine (FLT),
HIPAA SURVIVAL SKILLS: An Update University of Miami1 Marisabel Davalos, M.S.Ed., CIP Associate Director of Educational Initiatives November, 2008.
Challenges of Cancer Diagnosis in Resource Limited Settings Optimizing Pathology Support Ann Marie Nelson, M.D. AIDS and Infectious Disease Pathology Joint.
HIPAA THE PRIVACY RULE. 2 HISTORY In 2000, many patients that were newly diagnosed with depression received free samples of anti- depressant medications.
SMS Planning.  Safety management addresses all of the operational activities of the entire organization.  The four (4) components of an SMS are: 1)
SUPERVISION FRAMEWORK FOR CLEARING AND SETTLEMENT SYSTEMS: MAIN ELEMENTS AND SOME ISSUES TO INCLUDE IN THE OVERSIGHT OF THE SYSTEMS Global Payments Week.
Team Building: Critical Role of Interdisciplinary Research Teams in Translational Research C. Kent Osborne, M.D. Director, Lester and Sue Smith Breast.
Health Insurance portability and Accountability Act (HIPAA)‏
Data Quality Improvement This material was developed by Johns Hopkins University, funded by the Department of Health and Human Services, Office of the.
Information Security IBK3IBV01 College 3 Paul J. Cornelisse.
HIPAA and Human Subjects Research IRB Member CE May 2014 Slideshow by Sean Horkheimer.
Investigational Devices and Humanitarian Use Devices June 2007.
The Importance of Tissue Banking and Tissue Research Mark E. Sobel, M.D., Ph.D. Executive Officer, American Society for Investigative Pathology
Unit: Ethical and Legal.   Client Autonomy  The right of patients to make decisions about their medical care without their health care provider trying.
NCI/NAPBC Model Informed Consent for Future Research Use of Tissue Marianna Bledsoe Resources Development Branch, Cancer Diagnosis Program, National Cancer.
The TJU Human Research Protection Program (HRPP): Part I – Which Entities/Offices are Involved ? J. Bruce Smith, MD, CIP.
Revision N° 11ICAO Safety Management Systems (SMS) Course01/01/08 Module N° 9 – SMS operation.
Responsible Transparency MCC’s Experience with Microdata Protection and Dissemination Authors: Stephanie Burch, Heather Hanson, Jack Molyneaux, Jennifer.
NCI Division of Cancer Prevention Ongoing Activities at Frederick Facilities Presented By: Lori Minasian, M.D. Robert Shoemaker, Ph.D. October 1, 2015.
Business Continuity Planning 101
GCP (GOOD CLINICAL PRACTISE)
Juvenile Legislative Update 2013 Confidential Records and Protected Disclosures.
Cancer Clinical Trials Office Clinical Trials & Research Training Oct2014.
Tissue Collection & Banking Facility
Leveraging the Data Map – A Case Study November 15, 2016
Patricia M. Alt, Ph.D. Dept. of Health Science Towson University
RISK MANAGEMENT IN THE TREATMENT OF OPIOID DEPENDENCE
Confidential Records and Protected Disclosures
The HIPAA Privacy Rule and Research
What types of research are exempt and ohrp guidance on exemptions
Paul T. Smith, Esq. Partner, Davis Wright Tremaine LLP
IRB Harmonization 2016 Review
Presentation transcript:

Tissue Bank Challenges Repository and Pathologist View Elizabeth H. Hammond M.D.

2 Types of Challenges Repository managers Pathologists who provide tissue to banks

Repository Manager Challenges Confidentiality Tissue Accuracy Specimen Tracking Consent Tracking Specimen Disposition Which IRB?

Confidentiality Limited access to identified information Confidentiality agreements Security of identified information Retention of identified information Tracking of disclosure of information

Tissue Sample Accuracy Tissue samples and associated identifying information must be used to insure that samples received: –Represent tissue of study patient –Contain tissue of interest to the study –Do not contain artifacts which render tissue unusable for research

Specimen Tracking Sample identification Sample storage and retrieval Tracking of samples to/ from investigators Tracking of samples back to institutions Tracking of sample disposal

Consent Tracking Samples with/without consent Level of consent Patients decreased (with documentation)? Tracking of consent when samples used Sample reuse beyond study definition

Specimen Disposition Sample tracking/ retrieval to insure prompt return of samples Sample disposition when block expended Sample disposition when study closed

IRB Jurisdiction Which IRB has ethical oversight for the repository? Which IRB has ethical oversight when a study using tissue is approved by clinical trial group or other entity?

Repository Approaches Tracking issues require data bases Identified information must be secured and dispostion must be controlled by policy Data base security and access must be carefully controlled Local IRB coordinated approach to HBM issues must be arranged to insure uniform education about policies

Pathologist Challenges Patient Care Patient Consent Cost Malpractice Risk Ownership/credit

Patient Care Blocks may be needed for future clinical tests (Her2 in breast cancer) Retrospective review of samples when new risk factors found, new diagnoses considered Late requests for second opinions

Patient Consent What documentation should be requested? How should consent information be recorded? Institutional policies are highly variable as are the wishes of IRB’s.

Issue of Cost Pathologists are busier with smaller staffs Block selection for tissue banking is time consuming (expensive) –Reports, blocks, and slides must be obtained –Report and slides must be reviewed –Block must be selected and shipped –Documentation must be maintained

Issue of Malpractice Risk Retention of slides or blocks beyond the times mandated by regulatory agencies may be seen as promoting malpractice risk. –Can be used in litigation longer –Can be reviewed and diagnosis challenged –Policy must be specific and documented or patient can challenge removal of tissue from department which may promote litigation

Issue of Ownership Pathologists view blocks are potential valuable resource for own research. Issues of ownership vary by state Ownership becomes bargaining issue

Approaches to Patient Care Issues Uniform guidelines for tissue retention for patient care are needed that are not state specific and are widely endorsed and enforced by regulatory agencies such as CAP/JCAHO. Tissue requirements must be mindful of potential patient care needs (retention of unstained slides or availability of rapid return of materials when necessary)

Patient Consent Approaches Uniform consent form should be provided or education about key elements Process to assure proper procedures are followed should be available and simple Documentation guidelines or forms should be created/provided (?web based) Information should be available to pathologists to enable understanding of process

Approaches to Cost Mechanisms to provide payment and ease of submission/shipment of materials are needed. Uniformity of submission requirements would be helpful. Strategies for case identification are needed which are not disruptive to patient care

Malpractice Risk Approaches Pathologists should be informed about the value of standardized procedures and documentation in preventing malpractice risk Policies should be developed for situations of discrepant diagnoses which mitigate against malpractice risk

Approaches to Ownership Issues National guidelines are needed for determining ownership or establishing priority of granting tissue requests. Strategies for giving credit to pathologists for participation are needed which they accept. Access to tissue resources could be enabled for those providing tissue so that individual studies could be done.

Public Education Public opinion could be marshaled to promote tissue acquisition by publicizing results of studies where cooperation led to important new treatment strategies. Patient advocacy groups and oncology groups could promote tissue banking using media and individual pathologist contact.

Pathologist Cooperation Participation of all types of pathologists in creating solutions will promote cooperation. Involvement of pathology organizations as resources for information and guideline development will foster support. Communication about the impact of tissue banking on future cancer care will promote cooperation.